Efficacy and safety of oral anticoagulant versus antiplatelet therapy for secondary prevention of cardiovascular disease in patients without atrial fibrillation
G. D'Annunzio University, Institute of Cardiology and Center of Excellence on Aging, Chieti (Italy)
1
presentation
0
follower
4
more
presentations
in this session
A randomized, pharmacodynamic comparison of low dose ticagrelor (60mg bid) to low dose prasugrel (5mg od) in patients with prior myocardial infarction: the ALTIC-2 study